DK1017404T3 - Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom - Google Patents

Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK1017404T3
DK1017404T3 DK98944115T DK98944115T DK1017404T3 DK 1017404 T3 DK1017404 T3 DK 1017404T3 DK 98944115 T DK98944115 T DK 98944115T DK 98944115 T DK98944115 T DK 98944115T DK 1017404 T3 DK1017404 T3 DK 1017404T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
disease
Prior art date
Application number
DK98944115T
Other languages
English (en)
Inventor
Jean-Pierre Sachetto
William Jeffery Sandborn
William John Tremaine
Original Assignee
Celltech Pharma Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720590.0A external-priority patent/GB9720590D0/en
Priority claimed from GBGB9725346.2A external-priority patent/GB9725346D0/en
Application filed by Celltech Pharma Europ Ltd filed Critical Celltech Pharma Europ Ltd
Application granted granted Critical
Publication of DK1017404T3 publication Critical patent/DK1017404T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/723Xanthans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98944115T 1997-09-26 1998-09-25 Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom DK1017404T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9720590.0A GB9720590D0 (da) 1997-09-26 1997-09-26
GBGB9725346.2A GB9725346D0 (en) 1997-11-28 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease
EP98944115A EP1017404B1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
PCT/GB1998/002899 WO1999016454A1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
DK1017404T3 true DK1017404T3 (da) 2004-11-01

Family

ID=26312333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944115T DK1017404T3 (da) 1997-09-26 1998-09-25 Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom

Country Status (11)

Country Link
US (1) US7341741B1 (da)
EP (1) EP1017404B1 (da)
JP (2) JP4180791B2 (da)
AT (1) ATE269710T1 (da)
AU (1) AU758501B2 (da)
CA (1) CA2304948C (da)
DE (1) DE69824748T2 (da)
DK (1) DK1017404T3 (da)
ES (1) ES2224428T3 (da)
PT (1) PT1017404E (da)
WO (1) WO1999016454A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69011930T2 (de) 1989-04-21 1995-01-19 Du Pont Fungizide Oxazolidinone.
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
WO1999001579A1 (en) 1997-07-01 1999-01-14 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
WO1999060012A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
AUPP915099A0 (en) * 1999-03-12 1999-04-15 Monk, Michael Mendel Improved composition for oral administration
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
WO2004071453A2 (en) 2003-02-13 2004-08-26 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
JPWO2006028012A1 (ja) * 2004-09-07 2008-05-08 伯東株式会社 化粧料およびその製造方法
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
PL2294012T3 (pl) * 2008-05-07 2014-12-31 Salix Pharmaceuticals Inc Podawanie środka czyszczącego jelito i antybiotyku w leczeniu choroby jelit
RU2593939C2 (ru) 2008-11-13 2016-08-10 Ногра Фарма Лимитед Антисмысловые композиции и способы их получения и применения
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
WO2014011893A1 (en) 2012-07-11 2014-01-16 Mercy Medical Research Institute Colorectal delivery device
US9682101B2 (en) * 2013-03-25 2017-06-20 Ferring B.V. Composition for the treatment of disease
WO2018191752A1 (en) 2017-04-14 2018-10-18 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders
AU2020298261A1 (en) 2019-06-19 2022-01-20 Inx Medical, Llc Foamable composition for use in surgical diagnostic procedures
WO2021096479A1 (en) * 2019-11-11 2021-05-20 Trim-Edicine, Inc. Treatment for inflammatory bowel disease and radiation-induced intestinal injury

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924570A1 (de) * 1989-07-25 1991-01-31 Henning Berlin Gmbh Pharmazeutische zubereitung zur rektalen verabreichung
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
EP0586488B1 (de) * 1991-06-07 1995-05-03 Byk Gulden Lomberg Chemische Fabrik GmbH Pharmazeutische klistierzubereitung
WO1995016451A1 (fr) 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
US5691343A (en) * 1995-03-30 1997-11-25 Mayo Foundation For Medical Education And Research Use of topical azathioprine to treat inflammatory bowel disorders
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use

Also Published As

Publication number Publication date
JP2001517708A (ja) 2001-10-09
US7341741B1 (en) 2008-03-11
AU9178098A (en) 1999-04-23
AU758501B2 (en) 2003-03-20
JP4180791B2 (ja) 2008-11-12
EP1017404B1 (en) 2004-06-23
DE69824748T2 (de) 2005-08-25
PT1017404E (pt) 2004-11-30
EP1017404A1 (en) 2000-07-12
ATE269710T1 (de) 2004-07-15
CA2304948C (en) 2009-12-29
DE69824748D1 (de) 2004-07-29
CA2304948A1 (en) 1999-04-08
ES2224428T3 (es) 2005-03-01
JP2008143914A (ja) 2008-06-26
WO1999016454A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
ATE269710T1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
DZ2375A1 (fr) Prévention de la perte et restauration de la masseosseuse par certains agonistes des prostaglandine s.
NO974911D0 (no) Fremstilling og anvendelse av sulfaterte oligosakarider
TNSN91070A1 (fr) Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant.
DK0490649T3 (da) En fysisk form af N- 4- 5-(cyklopentyloxycarbonylamino)-1-methylindol-3-ylmethyl -3-methoxybenzoyl -2-methylbenzensulfonamid, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende den
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
NO942170L (da)
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DE58908155D1 (de) Endoprothese des hüftgelenks.
SE9602442D0 (sv) Administration of pharmaceuticals
TR28109A (tr) Duman halinde dezenfekte eden formülasyonlar.
ATE203246T1 (de) Dialkyltiacumicine
MX9602951A (es) Composiciones de metronidazol de liberacion modificada y metodos para fabricar y utilizar las mismas.
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DE69624308D1 (de) Bernsteinsäurederivate als abbaubare Chelatbildner, ihre Verwendungen und Zusammensetzungen
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
DK1017667T3 (da) 2-amino-6-methyl-7-acetyltetralin og farmaceutiske præparater til forebyggelse og terapeutisk behandling af inflammatoriske og/eller autoimmune patalogier
EP0683430A3 (en) Photographic processing compositions including a hydrophobically modified sizing agent.
NO913661L (no) Anordning og fremgangsmaate for dosering av vaskemiddelkompositter.
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.